Altogether, these results suggest that hBM-MSC-induced Gal-3 overexpression in the AML cell line stimulates β-catenin stabilization and activates the Wnt/β-catenin pathway in the AML cell line, which is critical for AML drug resistance. This evidence concerns the gene LGALS3 and acute myeloid leukemia.